Literature DB >> 17556534

The role of G protein-coupled receptor 40 in lipoapoptosis in mouse beta-cell line NIT-1.

Ying Zhang1, Mingtong Xu, Shaoling Zhang, Li Yan, Chuan Yang, Wensheng Lu, Yan Li, Hua Cheng.   

Abstract

Free fatty acids (FFAs) exert divergent effects on beta-cells. Acute exposure to FFAs stimulates insulin secretion, whereas chronic exposure impairs beta-cell function and induces apoptosis. The G protein-coupled receptor 40 (GPR40) is preferentially expressed in beta-cells and is activated by a wide range of FFAs. In this study, we used small interfering RNA technology and apoptosis assay in mouse beta-cell NIT-1 to address the role of GPR40 in beta-cell lipoapoptosis and function. Results showed that palmitate induced beta-cell apoptosis, which was not mediated through GPR40, whereas oleate protected NIT-1 cells from palmitate-induced lipoapoptosis, which was mediated at least in part through GPR40. Moreover, by detecting the activation of the phosphatidylinositol 3-kinase and MAP kinase (MAPK) pathways, we found that oleate promoted the activation of extracellular signal-regulated protein kinase-MAPK pathway mainly via GPR40, increased the expression of early growth response gene-1, leading to the anti-lipoapoptotic effect on NIT-1 cells. It was suggested that GPR40 might be implicated in the control of beta-cell mass plasticity and GPR40 probably provide a link between obesity and type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556534     DOI: 10.1677/JME-06-0048

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  24 in total

1.  Exendin-4 protects pancreatic beta cells from palmitate-induced apoptosis by interfering with GPR40 and the MKK4/7 stress kinase signalling pathway.

Authors:  Annalisa Natalicchio; Rossella Labarbuta; Federica Tortosa; Giuseppina Biondi; Nicola Marrano; Alessandro Peschechera; Emanuele Carchia; Maura Roberta Orlando; Anna Leonardini; Angelo Cignarelli; Piero Marchetti; Sebastio Perrini; Luigi Laviola; Francesco Giorgino
Journal:  Diabetologia       Date:  2013-08-31       Impact factor: 10.122

2.  miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression.

Authors:  Yan Li; Xuejuan Xu; Ying Liang; Shanying Liu; Huisheng Xiao; Feng Li; Hua Cheng; Zuzhi Fu
Journal:  Int J Clin Exp Pathol       Date:  2010-01-25

3.  NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity.

Authors:  Lan Shen; Xuewu Liu; Wugang Hou; Guodong Yang; Yousheng Wu; Rui Zhang; Xia Li; Honglei Che; Zifan Lu; Yuanqiang Zhang; Xinping Liu; Libo Yao
Journal:  Cell Mol Life Sci       Date:  2010-02-03       Impact factor: 9.261

4.  Structural requirements for the cytoprotective actions of mono-unsaturated fatty acids in the pancreatic beta-cell line, BRIN-BD11.

Authors:  S Dhayal; H J Welters; N G Morgan
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

Review 5.  Lipid receptors and islet function: therapeutic implications?

Authors:  M A Kebede; T Alquier; M G Latour; V Poitout
Journal:  Diabetes Obes Metab       Date:  2009-11       Impact factor: 6.577

6.  GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells.

Authors:  Sang-Kyu Park; Anja Herrnreiter; Sandra L Pfister; Kathryn M Gauthier; Benjamin A Falck; John R Falck; William B Campbell
Journal:  J Biol Chem       Date:  2018-05-18       Impact factor: 5.157

Review 7.  Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes.

Authors:  Bo Ahrén
Journal:  Nat Rev Drug Discov       Date:  2009-04-14       Impact factor: 84.694

Review 8.  Drugs or diet?--Developing novel therapeutic strategies targeting the free fatty acid family of GPCRs.

Authors:  H J Dranse; M E M Kelly; B D Hudson
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

9.  NADPH oxidase 2-derived reactive oxygen species mediate FFAs-induced dysfunction and apoptosis of β-cells via JNK, p38 MAPK and p53 pathways.

Authors:  Huiping Yuan; Xiaoyong Zhang; Xiuqing Huang; Yonggang Lu; Weiqing Tang; Yong Man; Shu Wang; Jianzhong Xi; Jian Li
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

10.  Reevaluation of fatty acid receptor 1 as a drug target for the stimulation of insulin secretion in humans.

Authors:  Robert Wagner; Gabriele Kaiser; Felicia Gerst; Elisabeth Christiansen; Maria E Due-Hansen; Manuel Grundmann; Fausto Machicao; Andreas Peter; Evi Kostenis; Trond Ulven; Andreas Fritsche; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetes       Date:  2013-02-01       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.